The stock market continues to rip higher, but a new group is taking the lead. If you want to follow institutional capital, smart money biotech stocks are exactly what you need to target right now.
For the last three months, it's been all about semiconductors. Micron, Intel, AMD. The big names have doubled, some even tripled off the April 1 lows.
That area is getting extended. A new area is taking control.
Why Are Smart Money Biotech Stocks Leading the Market Right Now?
Bottom Line: The semiconductor trade is extended, and institutional capital is rotating into biotechnology. IMVT and TGTX represent the clearest entry points in the new leading sector, with defined risk through tight stop losses. Getting into leading groups early, before the crowd recognizes the rotation, is the core edge that smart money biotech stock selection provides.
The big Wall Street shops, the ETFs, the hedge funds, the endowments, they all invest thematically. They go big into semiconductors when AI is booming. They buy nuclear stocks if there's a bottleneck. They buy airlines if the cyclical trend is in play.
When these institutions invest thematically, they buy all the stocks in that group. That's where the wind is at your back.
The areas that are outperforming are likely to continue outperforming. That's where the big money is buying. If you focus your stock picks in the leading areas, your odds of success increase dramatically.
How Do You Identify Which Sectors Institutional Money Is Buying?
An industry strength indicator is a huge tool for identifying which areas of the market are showing the most strength right now. When endowments and hedge funds invest thematically, they buy all the stocks in a specific group, creating a powerful tailwind that pushes the entire sector higher.
If you're not following the leading groups, you are not putting the odds in your favor.
The NBI Biotechnology Breakout
Right now, the biotechnology sector is breaking out strong. The ETF symbol for this group is NBI.
NBI trends beautifully. It had a strong run through the last half of 2025, steadily marching higher. Then it went into a four to five month consolidation period. The price action shallowed and tightened up.
Just over the last week, this area has been breaking out strong.
Biotech Stocks Already Running
The sector strength is obvious when you review the stocks already moving. The follow-through in the biotechnology area is real.
- Crystal Biotech: Came into the start of the year with a perfect, shallowing cup with handle pattern. Beautiful follow-through over the last couple of weeks.
- Nerra NT: Formed a nice big rounded base off the bottom with strong recent follow-through.
- RVMD: Big move up, a nice little shallowing consolidation, then pushed higher.
Strength in the sector and good follow-through in individual stocks. That's a really positive sign. These are the kinds of smart money biotech stocks that signal institutional buying across the group.
Get an entire year of live weekly mentoring sessions, my newsletter, indicators, bonus reports, and more.
Join my Black Ops Trading ClubWhich Biotech Stocks Are the Best Buys Right Now?
Two specific biotech stocks are breaking out with clean patterns and strong momentum. Both belong to a group just starting to show strength in a very strong market.
1. Immunovant (IMVT)
Immunovant is not a super wild stock, but it's a decent mover. It averages around four and a half percent a day.
This stock is up roughly 65% since the March lows. A pretty good pace, but nothing unrealistic.
Right now, it's putting in a nice, tight flag handle pattern. It made a good burst, and now it's consolidating and wedging out. You want to buy this on a break higher.
When this stock makes these little runs, it typically accelerates somewhere in the 25 to 30% range. If you buy the breakout at 39, you're risking five to try to make 20 or 25. That's a nice little swing trade setup.
2. TG Therapeutics (TGTX)
This one moves a little bit faster. TG Therapeutics is on a tear.
No big pullbacks after this huge run. Just in June, this stock is up 55%. There's no selling. No profit taking. No wild gyrations. Buyers are hammering it into these highs.
It is still being bought and is currently consolidating in a super tight little range. This stock moves five and a quarter percent on average in a given day, yet it spent three days in the exact same 5% range. It's tightening up, compressing that energy like a coiled spring.
Trading Leading Groups
You can buy a leading stock in a leading group with good momentum. There are no guarantees in the market. But buying clean patterns in strong sectors is the way to put the odds in your favor.
You need to know what to focus on, where to buy, where to get out, and how to keep your risk tight. When you align your capital with smart money biotech stocks, you're trading alongside the largest players in the market.
The Biotech Shift Is Here
The semiconductor area is getting extended. Capital is rotating, and the biotechnology sector is taking control.
Focus your attention on clean patterns, tight consolidations, and strict risk management.
Stocks like IMVT and TGTX offer defined risk with strong upside potential. Follow the institutional money, trade the leading groups, and keep your stop losses tight. That's how you find the best smart money biotech stocks before the crowd catches on.
Get an entire year of live weekly mentoring sessions, my newsletter, indicators, bonus reports, and more.
Key Takeaways
- Semiconductors like Micron, Intel, and AMD have doubled or tripled off April 1 lows, making the sector extended and ripe for rotation out.
- Institutional capital, including hedge funds, ETFs, and endowments, invests thematically by buying entire sectors at once, creating powerful tailwinds for all stocks in the leading group.
- The NBI Biotechnology Index is breaking out, signaling that smart money is rotating from semiconductors into biotech as the new leadership sector.
- IMVT and TGTX are the two specific biotech stock calls, selected for clean chart patterns, tight consolidations, and defined risk with strong upside potential.
- Focusing stock picks in sectors showing multi-timeframe strength, identified through an industry strength indicator, dramatically improves the odds of success.
DISCLAIMER: Traders Agency does not offer financial advice. The information provided is for educational purposes only and should not be considered financial advice. Traders Agency is not responsible for any financial losses or consequences resulting from the use of the information provided. Trading carries inherent risks and may not be suitable for all individuals. You are advised to conduct your own research and seek personalized advice before making any investment decisions, recognizing the potential risks and rewards involved.
See more from Traders Agency on Google
Make us a preferred source and our market analysis will appear more prominently in your Google Search, Top Stories, and AI results.
Add to Preferred Sources
